ESR1 and breast carcinoma: These results are consistent with the finding by Kong et al. (22) that FOXA1 and GATA3 are essential co-regulators in estrogen response pathway and that ESR1, FOXA1 and GATA3 formed an enhanceosome in breast cancer cells.